AUTHOR=Brouwer Marlies E. , Molenaar Nina M. , Burger Huibert , Williams Alishia D. , Albers Casper J. , Lambregtse-van den Berg Mijke P. , Bockting Claudi L. H. 

TITLE=Tapering Antidepressants While Receiving Digital Preventive Cognitive Therapy During Pregnancy: An Experience Sampling Methodology Trial

JOURNAL=Frontiers in Psychiatry

VOLUME=11

YEAR=2020

URL=https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.574357

DOI=10.3389/fpsyt.2020.574357

ISSN=1664-0640

ABSTRACT=<p><bold>Background:</bold> Previous studies indicated that affect fluctuations, the use of antidepressant medication (ADM), as well as depression during pregnancy might have adverse effects on offspring outcomes. The aim of the current proof-of-principle study is to explore the effect of tapering ADM while receiving online preventive cognitive therapy (PCT) on pregnant women and the offspring as compared to pregnant women continuing ADM.</p><p><bold>Objectives:</bold> We sought to compare positive and negative affect fluctuations in pregnant women receiving online PCT while tapering ADM vs. pregnant women continuing ADM, and to investigate if affect fluctuations in early pregnancy were related to offspring birth weight.</p><p><bold>Method:</bold> An experience sampling methodology (ESM)-trial ran alongside a Dutch randomized controlled trial (RCT) and prospective observational cohort of women using ADM at the start of pregnancy. In the ESM-trial fluctuations of positive and negative affect were assessed in the first 8 weeks after inclusion. Recurrences of depression were assessed up to 12 weeks post-partum, and birth records were used to assess offspring birth weight. The RCT has been registered at the Netherlands Trial Register (NTR4694, <ext-link ext-link-type="uri" xlink:href="https://www.trialregister.nl/trial/4551" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.trialregister.nl/trial/4551</ext-link>).</p><p><bold>Results:</bold> In total, 19 pregnant women using ADM at start of their pregnancy participated in the ESM-trial. There were no significant differences in positive and negative affect fluctuations, nor recurrence rates between women receiving PCT while tapering ADM vs. women continuing ADM. We found no association between affect fluctuations, pre-natal depressive symptoms, and birth weight (all <italic>p</italic> &gt; 0.05).</p><p><bold>Conclusion:</bold> This explorative study showed that tapering ADM while receiving online PCT may protect pregnant women against recurrences of depression and affect fluctuations, without affecting birth weight. There is a high need for more controlled studies focusing on tapering ADM with (online) psychological interventions during pregnancy.</p>